QVT Financial’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

QVT Financial’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-48,582	Closed	-$2.01M	–	81
2016 Q2	$2.01M	Sell	48,582 -121,617	-71%	-$5.29M	0.14%	70
2016 Q1	$6.92M	Sell	170,199 -76,649	-31%	-$2.63M	0.42%	57
2015 Q4	$10.2M	Sell	246,848 -121,514	-33%	-$4.07M	0.58%	43
2015 Q3	$5.67M	Sell	368,362 -38,095	-9%	-$819K	0.19%	64
2015 Q2	$10.1M	Hold	406,457	–	–	0.15%	61
2015 Q1	$9.29M	Sell	406,457 -91,935	-18%	-$2.32M	0.52%	49
2014 Q4	$13.5M	Sell	498,392 -147,313	-23%	-$2.54M	0.67%	41
2014 Q3	$7.57M	Hold	645,705	–	–	0.39%	63
2014 Q2	$10M	Buy	645,705 +344,199	+114%	+$4.94M	0.54%	52
2014 Q1	$5.93M	Buy	+301,506	New	+$5.12M	0.34%	63

Other funds holding FPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

QVT Financial's FPRX Position: Q3 2016 in Review

QVT Financial sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2016, closing a stake of 48,582 shares — an estimated $2.01M sold.

QVT Financial first reported a position in FPRX in Q1 2014 and held it in 10 quarters. The position peaked at $13.5M in Q4 2014. 176 funds tracked by Wall St. Rank hold FPRX as of Q3 2016.

QVT Financial reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
QVT Financial sold 48,582 Five Prime Therapeutics, Inc. shares in Q3 2016, an estimated $2.01M.
QVT Financial first reported a position in Five Prime Therapeutics, Inc. in Q1 2014 and held it in 10 quarters.
QVT Financial's Five Prime Therapeutics, Inc. position peaked at $13.5M in Q4 2014.
176 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2016.

Based on QVT Financial's 13F filing for Q3 2016, filed 14 Nov 2016.